After Patient Dies From Fecal Transplant, FDA Halts Trials Until Testing Improves For Drug-Resistant Bacteria

The transplants have come into increasing use to treat severe intestinal orders and sometimes work quickly in patients wasting away. But the procedure to use stool from a healthy donor to restore the normal balance of bacteria and other organisms in the intestine is considered experimental by the FDA.

from Kaiser Health News http://bit.ly/2Rpfmi5